Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rebound insomnia and newer hypnotics.

M Lader1

  • 1Institute of Psychiatry, De Crespigny Park, Denmark Hill, London, UK.

Psychopharmacology
|January 1, 1992
PubMed
Summary

Newer hypnotics like zolpidem may have less rebound insomnia than older benzodiazepines. Further research is needed to confirm these findings on sleep quality after medication discontinuation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A patient who changed my practice: Personality disorder or bipolar disorder?

International journal of psychiatry in clinical practice·2014
Same author

Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal.

European psychiatry : the journal of the Association of European Psychiatrists·2012
Same author

Plasma concentrations of tricyclic antidepressive drugs.

British journal of clinical pharmacology·2012
Same author

Caffeine withdrawal symptoms and rate of metabolism.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Buspirone treatment as an aid to benzodiazepine withdrawal.

Journal of psychopharmacology (Oxford, England)·2012
Same author

A comparison of augmenting central serotonin and noradrenaline function in healthy subjects: implications for studies on the neurochemistry of anxiety.

Journal of psychopharmacology (Oxford, England)·2012

Area of Science:

  • Pharmacology
  • Sleep Medicine
  • Neuroscience

Background:

  • Benzodiazepine hypnotics are widely prescribed for insomnia.
  • A significant side effect is rebound insomnia, where sleep worsens after stopping the medication.
  • Factors influencing rebound insomnia include drug properties and treatment duration.

Purpose of the Study:

  • To review the rebound insomnia potential of newer hypnotic agents.
  • To compare newer compounds (quazepam, zolpidem, zopiclone) with older benzodiazepines.
  • To assess the current evidence regarding reduced rebound insomnia with newer hypnotics.

Main Methods:

  • Literature review focusing on newer hypnotic compounds.
  • Analysis of studies examining rebound insomnia.
  • Consideration of selective benzodiazepine receptor agonists and atypical binders.
  • Emphasis on sleep laboratory and clinical data with individual patient analysis.

Main Results:

  • Limited evidence suggests newer compounds may have lower rebound insomnia potential.
  • Quazepam, zolpidem, and zopiclone are highlighted for their distinct receptor binding or atypical profiles.
  • Current data is consistent with claims of reduced rebound compared to older benzodiazepines of similar duration.

Conclusions:

  • Emerging evidence indicates newer hypnotics might offer reduced rebound insomnia.
  • Rigorous, further studies are essential to substantiate these preliminary findings.
  • The clinical acceptance of reduced rebound potential requires more definitive research.

Related Experiment Videos